Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.

Front Oncol · 2014 · PMC4178427 · PMID 25325015

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Furthermore, we identified a trend for increased frequencies of TAA- (but not FluM1-) specific CD4 + T cells as a function of disease stage, although this did not reach statistical significance (Figure 3 and data not shown).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.